The website Global Research provides at times interesting reading. It is edited by Michael Chossudovsky, an emeritus professor for economics. Unfortunately he at times writes about issues that are beyond his horizon.
In a recent piece, The Covid-19 Numbers Game: The “Second Wave” is Based on Fake Statistics, he falsely claims that the tests which are globally used to detect SARS-CoV-2 infections also react to other viruses and thereby deliver false results.
The method of the currently used SARS-CoV-2 test is based on the reverse transcription polymerase chain reaction (RT-PCR). The polymerase chain reaction can create millions of copies of RNA or DNA snippets fed into it:
Polymerase chain reaction (PCR) is a method widely used to rapidly make millions to billions of copies of a specific DNA sample, allowing scientists to take a very small sample of DNA and amplify it to a large enough amount to study in detail.
…
Thermal cycling exposes reactants to repeated cycles of heating and cooling to permit different temperature-dependent reactions – specifically, DNA melting and enzyme-driven DNA replication. PCR employs two main reagents – primers (which are short single strand DNA fragments known as oligonucleotides that are a complementary sequence to the target DNA region) and a DNA polymerase.
A clinical probe is taken from a human who may have the virus. In a preparation phase the probe is chemically cleaned and the outer hulls of viruses in it get destroyed. What is left includes the genetic material of the virus.
The genes of the SARS-CpV-2 are an RNA sequence with roughly 30,000 nucleotides. It is like a book with 30,000 characters on how to build the virus. It is unique for this virus. The researchers who developed the SARS-CoV-2 RT-PCR test have selected several unique snippets of about 100 nucleotides long out of the much longer string. Complementary oligonucleotides of the same length will then get synthesized. These are the primers for all following PCR tests.
The cleaned sample (10 to 200 µL), the primers and the polymerase are fed into a machine. Repeated cycles of heating and cooling will each multiply the number of RNA snippets in the sample. Luminescent markers are added to get an automatically readable result. Typically some 20-25 cycles are needed to detect the virus RNA snippets of an acute infection. When more cycles (typically up to 40) are used even a minimal amount of a specific virus RNA snippet can be detected. The process is highly automated.
Chossudovsky has not understood how the above process works. Specifically he has not understood that the selection of the oligonucleotides for the primer is very specific to the type of virus the test is supposed to detect.
Thus he is wrong when he writes:
According to Dr. Pascal Sacré, “these tests detect viral particles, genetic sequences, not the whole virus”
What this means is that the PCR test cannot detect or identify SARS-CoV-2. What it detects are fragments, which suggests that a standard “PCR positive” cannot be equated to a so-called Covid-19 Positive.
The PCR test will pick up fragments of several viruses including corona viruses as well as influenza (flu viruses A and B)
While SARS-2 which causes Covid-19 is considered to be similar to SARS-CoV-1, it has similar symptoms to seasonal influenza (Viruses A and B). Moreover, some of its milder symptoms are similar to those of the common cold corona viruses. According to the CDC: “Sometimes, respiratory secretions are tested to figure out which specific germ is causing your symptoms. If you are found to be infected with a common coronavirus (229E, NL63, OC43, and HKU1), that does not mean you are infected with the 2019 novel coronavirus.”
According to the CDC there are “seven [human] coronaviruses that can infect people” the first four of which (alpha, beta) are associated with the common cold.
…
In the above context, what this means is that a PCR test will pick up fragments of corona as well as influenza viruses. It will not be able to identify individual viruses including SARS-2.“Fragments of viruses positive” does not mean “SARS-2 positive” (or Covid-19 Positive). The PCR test may pick up fragments of influenza viruses (A, B) as well as common cold beta coronaviruses (e.g. OC43, HKU1).
This highlighted passages are as wrong as one can possibly get it wrong. The RT-PCR tests for SARS-CoV-2 DO NOT detect other types of viruses.
We know this because the folks who developed the test the WHO recommends to use have written about their development process:
We downloaded all complete and partial (if > 400 nt) SARS-related virus sequences available in GenBank by 1 January 2020. The list (n = 729 entries) was manually checked and artificial sequences (laboratory-derived, synthetic, etc), as well as sequence duplicates were removed, resulting in a final list of 375 sequences. These sequences were aligned and the alignment was used for assay design (Supplementary Figure S1). Upon release of the first 2019-nCoV sequence at virological.org, three assays were selected based on how well they matched to the 2019-nCoV genome (Figure 1). The alignment was complemented by additional sequences released independently on GISAID (https://www.gisaid.org), confirming the good matching of selected primers to all sequences.

bigger
The selected oligonucleotide assays, each specific for a certain snippet of the SARS-CoV-2 virus RNA, were then tested for their sensitivity and chemical stability.
They were also tested for cross-reactivity with other viruses:
Cell culture supernatants containing all endemic human coronaviruses (HCoV)‑229E, ‑NL63, ‑OC43 and ‑HKU1 as well as MERS-CoV were tested in duplicate in all three assays (Table 2). [..] Additional undiluted (but not quantified) cell culture supernatants were tested as summarised in Table 2. These were additionally mixed into negative human sputum samples. None of the tested viruses or virus preparations showed reactivity with any assay.
In total 297 clinical samples with 23 different human virus types in them were tested. The newly developed assays developed to find only SARS-CoV-2 reacted with none of those.

bigger
The PCR test for SARS-CoV-2 has a high specificity. It can not detect other types of viruses.
There are additional safety procedures to avoid false tests.
Each test run of typically 90 to 120 samples will include one quality control sample with a known quantity of the SARS-CoV-2 virus RNA. It will also include one quality control sample that is guaranteed to contain no virus RNA. At the end of each run the results of both quality assurance samples will be compared with the expected value. If there is any mismatch the whole run it will be repeated with fresh sample extracts.
When the laboratory machine runs the SARS-CoV-2 PCR test it also will also note the number of cycles it needed for each sample to first detect a reaction. That will typically be in the 20-30 cycles range. If a detection is only made towards the end of the 40 cycle program the machine will note this and alert its operator. Tests which only show positivity above 35 cycles will usually get repeated as such a low reactivity may point to a potential sample contamination.
Where a coronavirus test can go wrong is at the point of sample taking. The swab that is used may not have picked up enough gunk to catch a significant number of viruses. The PCR test will then show the person as negative even when it has caught SARS-CoV-2. There can also be bureaucratic errors where the sample is attributed to the wrong person. The test protocols are designed to prevent this and such cases are rare.
When a person gets infected with SARS-CoV-2 and starts to reproduce the virus its numbers explode to billions of copies per milliliter. When the immune system starts to defeat the virus the number will go down. Debris of dead virus may still be in the body four to five weeks after the infection onset even when the person is no longer infectious. The graphic below shows which test reacts at which stage of an infection.

bigger
A person that is tested PCR-positive for SARS-CoV-2 will have been infected with the virus. There is no other way to pick up the RNA snippets the PCR test is looking for. But that person may not have developed COVID-19 symptoms and may no longer be infectious. We do not know this for sure. Tests to find out if a person still spreads viable viruses take a several days and require a lot of manual labor in high security laboratories. These can not be done for everyone.
To recap:
- The PCR test for SARS-CoV-2 is highly specific for that virus and does not detect any other ones.
- A positive PCR tests demonstrates that the person has or has had the virus.
- We have no practical way to tell if that person, even when it shows no symptoms, is still infectious and spreading the disease.
The only way to prevent new infections coming from a PCR-positive person is to isolate that person. After 10 days the immune system of most people will have defeated the virus. (That a significant number of people are still ill at that point is the consequence of an exaggerated immune reaction to the virus, not of the virus itself.)
It is sad that an otherwise useful site like Global Research is spreading such false information about the Coronavirus pandemic. Chossudovsky should stick to writing about social issues. He obviously lacks the basic hard science knowledge that is necessary to understand how PCR tests work.
Spreading such unqualified statements during a pandemic like Chossudovsky's piece does is highly irresponsible.
That is the reason why I delete comments at this site with spread similar nonsense.